Klotho Neurosciences (KLTO) Competitors

Klotho Neurosciences (NASDAQ:KLTO) and Foghorn Therapeutics (NASDAQ:FHTX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, valuation, media sentiment, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.

Do analysts prefer KLTO or FHTX?

Foghorn Therapeutics has a consensus price target of $12.13, suggesting a potential upside of 167.07%. Given Foghorn Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Foghorn Therapeutics is more favorable than Klotho Neurosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Klotho Neurosciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Foghorn Therapeutics	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	3.13

Does the MarketBeat Community favor KLTO or FHTX?

Foghorn Therapeutics received 47 more outperform votes than Klotho Neurosciences when rated by MarketBeat users.

Company	Underperform	Outperform
Klotho Neurosciences	N/A	N/A
Foghorn Therapeutics	Outperform Votes 47 66.20%	Underperform Votes 24 33.80%

Is KLTO or FHTX more profitable?

Klotho Neurosciences has a net margin of 0.00% compared to Foghorn Therapeutics' net margin of -357.53%.

Company	Net Margins	Return on Equity	Return on Assets
Klotho Neurosciences	N/A	N/A	-25.89%
Foghorn Therapeutics	-357.53%	N/A	-30.98%

Do institutionals & insiders have more ownership in KLTO or FHTX?

20.1% of Klotho Neurosciences shares are held by institutional investors. Comparatively, 61.5% of Foghorn Therapeutics shares are held by institutional investors. 26.7% of Klotho Neurosciences shares are held by insiders. Comparatively, 7.6% of Foghorn Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Does the media refer more to KLTO or FHTX?

In the previous week, Klotho Neurosciences had 14 more articles in the media than Foghorn Therapeutics. MarketBeat recorded 16 mentions for Klotho Neurosciences and 2 mentions for Foghorn Therapeutics. Foghorn Therapeutics' average media sentiment score of 0.93 beat Klotho Neurosciences' score of 0.32 indicating that Foghorn Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Klotho Neurosciences	2 Very Positive mention(s)	1 Positive mention(s)	12 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Foghorn Therapeutics	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk & volatility, KLTO or FHTX?

Klotho Neurosciences has a beta of 0.18, suggesting that its stock price is 82% less volatile than the S&P 500. Comparatively, Foghorn Therapeutics has a beta of 3.04, suggesting that its stock price is 204% more volatile than the S&P 500.

Which has preferable valuation and earnings, KLTO or FHTX?

Klotho Neurosciences has higher earnings, but lower revenue than Foghorn Therapeutics. Klotho Neurosciences is trading at a lower price-to-earnings ratio than Foghorn Therapeutics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Klotho Neurosciences	N/A	N/A	$1.35M	-$0.36	-5.56
Foghorn Therapeutics	$23.50M	10.77	-$98.43M	-$1.36	-3.34

Summary

Foghorn Therapeutics beats Klotho Neurosciences on 10 of the 16 factors compared between the two stocks.